EVIDENCE-BASED PRACTICE: Imaging in Irritable Bowel Syndrome
O'Connor et al practice accounts for a considerable portion of the economic burden associated with IBS ( 2 ) . With a prevalence of approximately 14%-24% in women and 5%-19% in men, IBS is responsible for 2.4-3.5 million physician visits per year in the United States at a cost of $1.6 million ( 2 ). The purpose of this systematic review (SR) was to critically evaluate the current literature in an effort to establish the current role of radiologic imaging (computed tomography [CT] , magnetic resonance [MR] imaging, ultrasonography [US], fl uoroscopy, conventional fi lm radiography) in IBS. An important step in attempting to answer the above question was to address the following issues: current recommendations guiding radiologic imaging in IBS, radiologic imaging in patients with IBS without symptoms concerning for underlying structural disease, and radiologic imaging in patients with IBS with symptoms concerning for underlying structural disease.
Materials and Methods

Literature Search
The literature was searched and evidence was appraised independently by two reviewers, one (S.E.M.) with 7 years of radiology experience and recent completion of a 7-month course of radiologists, with a consequential lack of IBS-related research in the radiologic literature. On one hand, clinicians, mindful of the nonspecifi c nature of gastrointestinal symptoms such as abdominal pain and discomfort and disturbed defecation, fear missing something, while, on the other hand, unnecessary radiologic imaging is wasteful of resources and potentially exposes patients unnecessarily to ionizing radiation. Although no data exist on this issue, it is likely, given the reported prevalence of IBS, that considerable resources are expended on unnecessary radiologic imaging in patients with IBS. It has been shown that extensive diagnostic testing in patients meeting the symptom-based criteria for IBS has a low pretest probability of fi nding structural disease, and this I rritable bowel syndrome (IBS) is a chronic gastrointestinal condition characterized by abdominal discomfort, bloating, and disturbed defecation ( 1, 2 ) . Because IBS lacks characteristic imaging features and there are currently no diagnostic biomarkers, symptom-based criteria (Manning and Rome I-III) are recommended for diagnosis ( Table 1 ) (3) (4) (5) (6) . The Rome III (2006) criteria, for example, were reported to have a sensitivity of 70% and a specifi city of 90% for IBS in a study of 328 patients with a clinical diagnosis of IBS ( 7 ) .
In clinical practice, however, radiologic imaging is performed in many patients with IBS, particularly in those with so-called alarm symptoms ( Table 2 ) (ie , symptoms concerning for underlying structural disease, which might be misclassifi ed as IBS [ 9 ] ). There is a paucity of information regarding the appropriate use of abdominal imaging in patients with IBS, and few studies have investigated typical diagnostic yields in this setting ( 10 ) . As a result, the role of radiologic imaging in IBS is poorly defi ned, and there appears to be a lack of clinical or research interest in IBS among
Implications for Patient Care
On the basis of current, albeit n limited, best evidence, we conclude that patients fulfi lling the symptom-based diagnostic criteria for IBS and who do not exhibit concurrent potentially worrisome symptoms such as blood in stool, weight loss, recurrent fevers, anemia, and chronic severe diarrhea and who have no family history of colorectal cancer, infl ammatory bowel disease, or celiac sprue do not require radiologic imaging.
Current evidence suggests that n radiologic imaging is required in patients with concerning symptoms who fulfi ll the symptombased diagnostic criteria for IBS.
Optimal radiologic imaging of the n patient with IBS should be guided by the likely alternative diagnosis and adherence to the relevant American College of Radiology Appropriateness Criteria.
Endoscopy appears more suitable n than radiologic imaging for colonic investigation of patients with diarrhea-predominant and mixed-type IBS owing to the requirement to exclude microscopic or lymphocytic colitis by using biopsy.
Advances in Knowledge
The current evidence guiding the n performance of radiologic imaging in patients with irritable bowel syndrome (IBS) is insufficient; no systematic review (SR) focusing solely on IBS exists in the literature, and further study is therefore required. 
Secondary Literature Search
The search that formed the basis of this SR initially focused on the secondary literature (evidence-based reviews, syntheses, or guidelines that follow evidence-based practice methods) ( 11 ) . Initially, the broad search term "irritable bowel syndrome" was deliberately chosen to achieve a high sensitivity in the search for relevant SRs. 
Appraisal
Abstracts of articles retrieved from the primary and secondary literature were reviewed to identify articles that reported (a) current recommendations guiding radiologic imaging in IBS and described previously in radiology literature ( 11-13 ). ( 28 ). Unfortunately, the diagnostic yield of radiologic imaging was not detailed by Vanner et al ( 28 ) for the 11 of 30 patients with IBS who underwent barium enema prior to enrollment. In addition, 24% (23 of 95) of patients underwent US prior to referral to a gastroenterology clinic; presumably, these investigations would have excluded a number of other patients from the study. Fifty-eight of 95 patients fulfi lling the Rome criteria and lacking concerning symptoms for structural disease underwent either barium enema or colonoscopy; however, the proportion of barium enema examinations performed and the fi ndings of these studies were not reported ( 28 ) . The yield of radiologic imaging in patients who were subsequently found not to have IBS was not provided. Treacher et al ( 31 ) , which was published in 1986, exclusively studied radiologic imaging (barium enema) in IBS and did not use any specifi c criteria for the diagnosis of IBS. In this retrospective study, patients had a clinical diagnosis of IBS at a fi rst clinic visit after review by a physician in training or an attending gastroenterologist. Patients were excluded if there was a history of weight loss or blood per rectum; there was no control group, and all patients underwent sigmoidoscopy. An article by Francis et al ( 32 ) investigated radiologic imaging (US) in IBS and studied patients who fulfi lled the Rome criteria for IBS, after excluding those with abnormal hematologic and biochemistry fi ndings or who had frank or occult blood detected at stool examination. Because US was used for radiologic imaging, the bowel could not be examined, and all patients required sigmoidoscopy ( 32 ) . On the other hand, an article by Tolliver et al ( 30 ) studied the yield of biochemical, hematologic, and lactose hydrogen breath testing and structural imaging in patients meeting the clinical criteria for articles (one SR [ 2 ] from the TRIP database and three evidence-based guidelines from the National Institute for Health and Clinical Excellence database [ 23, 24 ] and from the TRIP database [ 25 ]). These reviews or guidelines comprehensively investigated many aspects of diagnosis and management of IBS including some analysis of radiologic imaging, although their primary focus was not imaging. These fi ve articles were selected as representing the current best evidence regarding radiologic imaging in IBS.
Focused Clinical Question
Primary Literature Search
The PubMed search yielded 1451 studies, 111 of which were potentially relevant after abstract review ( 26 ). The 1340 articles excluded referred to some aspect of IBS, but on review of the article's abstract, there was no reference to the issue of radiologic imaging in IBS.
Review of the short-listed articles ( n = 111), supplemented, where necessary, by review of full-text versions, identifi ed two additional SRs ( 10,27 ), both of which included Brandt as an author; the second SR published in 2009 was considered more valid to the current SR. In addition, fi ve valid primary research articles ( 28-32 ) were identifi ed, in which there was some focus on the issue of radiologic imaging in IBS. IBS was diagnosed by using symptom-based criteria in all but one article (Manning, Rome, or modifi ed Rome criteria). These articles studied radiologic investigation of patients with IBS to a variable extent ( Table 3 ) . Five articles at least partially studied radiologic investigations in IBS (barium enema examination, US). Only two studies specifi cally addressed the role of radiologic imaging in IBS ( 31, 32 ) : barium enema examination exclusively in one ( 31 ) and US in another ( 32 ) . Grading of the levels of evidence and recommendation of these studies by using evidence-based practice criteria is summarized in Table 4 . The quality of the methods of the retrieved studies was either moderate or low (grade 2B-4). Unfortunately, the articles with moderate quality evidence-based practice grading (retrospective cohort studies) 
Data Extraction and Analysis
For studies that investigated radiologic imaging in patients with IBS symptoms, data extracted included (a) the population studied, including the proportion of female patients, (b) the type of symptom-based criteria used (Manning [ 3 ] , Rome I, II, or III [4] [5] [6] , American College of Gastroenterology [ 10 ] , World Gastroenterology Organization [ 12 ]), (c) the type of intervention (diagnostic evaluation performed and reference standard comparison, if applied), (d) outcomes (prevalence of confi rmed structural gastrointestinal disease, resulting in an alternative diagnosis), and (e) statistical analyses pertaining to the accuracy of radiologic imaging tests, including sensitivity, specifi city, positive predictive and negative predictive values, confi dence intervals, positive likelihood ratio, and negative likelihood ratio ( 2, 7, 12, 13, 19, 20 ) . These statistical analyses were performed by using the online KT Clearinghouse Statistics Calculator funded by the Canadian Institute for Health Research ( 21 ) .
Results
Secondary Literature Search
No SR focused solely on the use of radiologic imaging in IBS was found. The highest level of evidence in the secondary literature (UpToDate) contained one article; that article did not focus solely on the role of radiologic imaging in IBS but discussed imaging among other issues in IBS ( 22 ) . Searches of lower levels of evidence in the secondary literature yielded four additional relevant
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only 27% (seven of 26) of patients with indicators of structural disease actually had a structural abnormality identifi ed. Again, although imaging was used to evaluate some patients, no data were presented specifi cally referring to radiologic imaging. Four of the articles in the primary literature ( 28, (30) (31) (32) examined 200 or fewer patients with IBS, which is a relatively small number for a common disorder of considerable heterogeneity. Only one article reported suffi cient data pertaining to radiologic imaging to allow statistical analysis ( Table 5 ). The results reported by Treacher et al ( 31 ) suggest that US has a sensitivity of 96% and specifi city of 95% for the detection of a structural abnormality in patients with IBS. No primary literature article studied CT, which would be most likely to offer the best one-stop imaging examination of the abdomen. The fl aws, listed previously, which affect all of the articles in different ways, detracted from the strength of the conclusions or recommendations that could be drawn in this review. Current recommendations guiding radiologic imaging in IBS.-Radiologic imaging in patients with IBS was discussed in part by guidelines written by the American College of Gastroenterology task force ( 27 ) . This task force recommended that for diarrhea-predominant IBS, "it is appealing to suggest that IBS-type symptoms, but the proportion of patients who required imaging, the type of imaging, and their results were not documented ( 29 ) . Treacher et al ( 31 ) noted that 27% (nine of 34) of patients with structural disease had an indicator of underlying disease and that IBS. The selection criteria used in this article therefore would suggest that a different patient cohort was examined than that in the article by Francis et al ( 32 ) . Only one article quantifi ed the effect of concerning symptoms on the diagnosis of disease in patients with ( 27 ) . Structural disease was found in only 1.3% (eight of 636) of patients (95% confi dence interval: 0.06%, 2.3%) ( Table 6 ) ( 27 ) . The incidence of many structural diseases, such as infl ammatory bowel disease, colorectal cancer, and gastrointestinal infection, was very low in patients with IBS and comparable with that of the general population; the prevalence of celiac disease and lactose intolerance, in contrast, seemed to be slightly higher in the IBS population ( 27 ) . The American College of Gastroenterology task force also referenced an interim analysis of a prospective controlled multicenter trial conducted in the United States that compared colonoscopy in 216 patients with diarrhea-predominant IBS or mixed diarrhea and constipation-type IBS with 416 control subjects undergoing screening for colorectal cancer and found no difference in the prevalence of colorectal cancer between patients with IBS and control subjects (IBS, 0% ( 27 ) . Therefore, the American College of Gastroenterology SR concluded that colonic imaging was not required routinely in patients with IBS who were younger than 50 years in the absence of symptoms suggestive of underlying structural disease. necessarily symptoms concerning for underlying structural disease. Structural disease was found in 12 patients (84 underwent barium enema), including uncomplicated diverticular disease and polyps but no cancer or infl ammatory bowel disease ( 31 ) . Patients with positive fi ndings had biochemical or hematologic abnormalities that would have merited further examination. A prospective study of 1452 patients with IBS, irrespective of the presence of symptoms concerning for underlying structural disease, identifi ed colonic disease in 2% (seven of 306) after colonoscopy or sigmoidoscopy with barium enema ( 29 ) . Diagnostic imaging depicted an alternative cause for abdominal pain in four of these seven patients. Therefore, it was concluded that the low yield, cost, and inconvenience of diagnostic investigations should precipitate reevaluation of investigation patterns ( 29 ) .
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Routine US in patients with IBS is currently not indicated on the basis of the only primary literature article on this topic ( 32 ) . Pathologic fi ndings were found by using US in 22 of 125 patients (20 of 100 female patients and two of 25 male patients) with a diagnosis of IBS by using Rome I criteria ( 32 ) . Gallstones, benign liver abnormalities, uterine fi broids, and adnexal cysts were found in female patients, and gallstones and hepatic steatosis were found in male patients. None of these abnormalities resulted in additional therapy. Hepatobiliary abnormalities were found in similar proportions of male and female patients (10% [10 of 100] vs 8% [two of 25]). Although gallstones were the most common abnormal hepatobiliary fi nding, they were not considered to entirely account for the presenting symptoms in any patient. Both this study and another, which evaluated diagnostic tests in IBS (including US) ( 28 ) , suggested that routine US was not necessary and may be counterproductive because of incidental fi ndings, which could lead to further diagnostic and therapeutic dilemmas, investigations, and interventions, with potential for distress for the patient ( 28, 32 ) . No specifi c guidelines for CT, MR imaging, fl uoroscopy, or diarrhea-predominant symptoms undergo colonoscopy with inspection of the distal ileum to exclude colon cancer and IBD [infl ammatory bowel disease], respectively." It was noted that lymphocytic or microcytic colitis (2.3% [fi ve of 216]) and nonspecifi c infl ammation (1.9% [four of 216]) only occurred in patients with diarrhea-predominant IBS, and hence it was recommended that colonoscopy, when required, should include random colonic biopsies ( 27 ) . Therefore, according to these guidelines, colonic investigation of diarrhea-predominant IBS and mixed diarrhea and constipation-type IBS subgroups with barium enema or CT colonography is not appropriate because of inability to perform random biopsies. However, in patients with constipation-predominant IBS, the task force did not recommend any one colonic investigation over another (colonoscopy, CT colonography, or barium studies) to exclude causes of mechanical obstruction ( 27 ) .
SR-based guidelines addressed the use of colonic imaging, abdominal US, and CT in IBS ( 2 ). These guidelines suggested performance of these investigations should be infl uenced by the likely underlying disease ( 2 ) . The American College of Gastroenterology SR emphasized that physicians experienced in IBS are less likely to order diagnostic tests than physicians with less experience, many of whom view IBS as a diagnosis of exclusion ( 27, 32 ) . One primary literature article ( 28 ) reported that the positive predictive value of the Rome I criteria for the diagnosis of IBS in patients without concerning symptoms was 100% and 98%, in retrospective and prospective patient groups, respectively. Nevertheless, 66% (41 of 62) of these patients with IBS younger than 45 years who did not have concerning symptoms had at least a partial investigation of the colon performed ( 28 ) .
Another primary literature article ( 31 ) (47) (48) (49) . One SR demonstrated that the prevalence of structural disease in patients meeting symptom-based criteria for IBS was comparable with that of the general population ( 2 ) . The exclusion of structural disease does not appear to be a valid justifi cation for indiscriminate radiologic imaging in IBS. In the absence of worrisome symptoms, current advice on colon cancer screening in patients with IBS should be no different than in the normal population ( 50 ) . It appears that early referral to a physician expert in IBS may be preferable to embarking on radiologic imaging, with a very low pretest probability of yielding structural disease. Physicians with expertise in IBS are less likely to order diagnostic tests than those without such a background ( 51 ) . A study community surveys in western Europe and North America suggest a prevalence of around 11.5% (4828 of 41 984) in the adult population ( 34 ) . While many of those affected do not seek medical attention and manage their symptoms by dietary changes and the use of a variety of remedies, a substantial minority have frequent and disabling symptoms that may incur a substantial effect on quality of life. Although the precise cause of IBS is not known, both psychologic and emotional factors and chronic stress have been regarded as important precipitating factors in the induction of IBS symptoms. While, more recently, enteric infection, food intolerance, and immune activation and disturbances in the colonic and small intestinal microfl ora have been proposed as playing a role in the pathophysiology of IBS ( 35 ), disordered intestinal motility and visceral hypersensitivity have long been regarded to be of primary importance ( 36 ) . However, the precise nature of the relationship between any one of these factors and the clinical presentation and/or natural history of IBS has yet to be elucidated. The diagnosis of IBS currently rests, therefore, on symptoms alone or, more precisely, on an aggregation of clinical symptoms.
Imaging in patients with IBS has serious implications for health care resources; IBS accounts for 1.7-10 billion U.S. dollars in direct medical costs in the United States without substantial supportive evidence for their value ( 11,37-41 ). A Canadian study of patients
Radiologic imaging in patients with
IBS with symptoms concerning for underlying structural disease.-The American College of Gastroenterology review of the utility of symptoms of concern for the presence of underlying colorectal cancer diagnosis is summarized in Table 7 ( 27 ) . There is evidence that patients presenting with IBS who have a family history of colorectal cancer, infl ammatory bowel disease, and celiac disease are at higher risk for structural disease ( 27 ) . Overall, the American College of Gastroenterology suggested "that the accuracy of alarm symptoms for identifying patients with underlying structural disease is disappointing" ( 27 ) . It also suggested that rectal bleeding and nocturnal pain offer little discriminative value in separating patients with IBS from those with structural diseases and stated that "whereas anemia and weight loss have poor sensitivity for structural diseases, they offer good specifi city" ( 27 ) . The American College of Gastroenterology concluded that "in patients who fulfi ll the symptom-based criteria of IBS, the absence of selected alarm features, including anemia, weight loss, and a family history of colorectal cancer, IBD [infl ammatory bowel disease] or celiac sprue, should re-assure physicians that the diagnosis of IBS is correct" ( 27 ) .
Discussion
IBS is one of the most common disorders encountered in modern medicine; The heterogeneity of the IBS cohorts affects the strength of the articles we analyzed and, therefore, that of our fi ndings and conclusions. Some studies investigated diagnostic imaging in patients with IBS regardless of the presence or absence of symptoms of concern, whereas others only included patients with IBS with worrisome symptoms. There were additional potential limitations in the fi ve primary literature articles. Four articles examined 200 patients with IBS or fewer, which represents a relatively small number and limits the recommendations that can be drawn ( 28, (30) (31) (32) . In addition, the IBS populations investigated did not always exclude patients who had already undergone diagnostic tests prior to referral to a specialist center. Thus, it is possible that some patients with IBS may have had structural disease already diagnosed or excluded prior to specialist referral, because those with abnormal biochemical or hematologic fi ndings were excluded ( 32 ) . These factors represent a possible explanation for the large range (2% [seven of 306]-23% [26 of 114]) in the prevalence of structural disease in the studies where be restricted to patients with typical meal-provoked symptoms, because patients with IBS with asymptomatic gallstones are in danger of being subjected to unnecessary cholecystectomy, without benefi t to their pain ( 9 ) .
With regard to the use of barium enema or CT colonography in IBS, there is little evidence in the literature. The American College of Gastroenterology guidelines suggest that where further investigation is required, diarrhea-predominant IBS and mixed diarrhea and constipation-type IBS should have colonoscopy supplemented by colonic biopsy, rather than barium enema or CT colonography ( 27 ) . The additional yield of colonoscopy may still be limited even in these groups, given the results of a recent study of patients with nonconstipation IBS. It was found that there was no increased incidence of structural abnormalities in 466 patients with IBS and 451 control subjects after colonoscopy ( 54 ) . The American College of Gastroenterology task force does not recommend any one colonic investigation in particular (colonoscopy, CT colonography, or barium studies) for the investigation of patients with constipation-type IBS to exclude mechanical obstruction ( 27 ) . The American College of Radiology Appropriateness guidelines for colorectal cancer screening would suggest, however, that CT colonography and double-contrast barium enema examination are not appropriate in high-risk patients, but that CT colonography is appropriate for middle-and low-risk patients and double-contrast barium enema should be considered when CT colonography is unavailable ( 50, 53 ) . It must also be conceded that the use of treatment failure as a criterion for further assessment has not been studied in IBS and could well prove unhelpful given the poor record of available therapies in the management of IBS.
There are a number of potential methods of improving the evidence base relating to the use of radiologic imaging in IBS. As a starting point, a retrospective study could document factors that precipitate imaging in a well-defi ned cohort of patients with IBS and calculate of diagnostic costs in children with IBS found that pediatricians use imaging even less frequently than gastroenterologists ( 52 43) , and 0%, respectively, among pediatricians. The cost of medical evaluation, including colonoscopy, but excluding upper gastrointestinal endoscopy, was fi ve times greater in children seen by a gastroenterologist than a pediatrician, even though there was no difference in symptoms between the groups. It was concluded that parent perception of the child's symptoms could be the primary factor driving investigations ( 52 ) .
The question of whether radiologic imaging is required for patients with IBS with symptoms that are potentially suggestive of underlying structural disease is a complex one, because their presence may, on the one hand, be deemed suggestive of underlying structural disease but, on the other hand, they by no means exclude the diagnosis of IBS ( 6 ) . In patients with concerning symptoms, or in patients with IBS in whom initial treatment has failed to control symptoms, the choice of imaging modality should be infl uenced by likely underlying disease. Therefore, we suggest that radiologic imaging in patients with IBS should be guided by the American College of Radiology Appropriateness Criteria (gastrointestinal imaging) and that the choice of imaging investigation should be infl uenced by the likely differential diagnoses or typical symptom ( 53 ). For example, in a patient with right upper quadrant pain with biliary features, American College of Radiology Appropriateness Criteria recommend abdominal US fi rst ( 53 ). Spiller suggests that only rarely should sphincter of Oddi dysfunction be considered, such as when pain is associated with a rise in liver enzymes or serum amylase level ( 9, 53 13 . Dodd JD . Evidence-based practice in radiology: steps 3 and 4-appraise and apply colonic investigations were performed. Restriction of our search to English language literature represented one of the potential weaknesses of this review.
We did search for unpublished data, although we did not encounter any relevant unpublished data from scientifi c meetings. Our conclusions were limited by the lack of good evidence, but this also helps to highlight the need for further investigation in this area.
The main fi nding of this review was that there is a paucity of rigorously designed trials that address the use of diagnostic imaging in IBS. This lack of adequate information also precludes the conduction of a meta-analysis, which is one of the best ways of providing data to guide one's practice. There is no doubt that there is a need for a welldesigned evaluation of imaging in IBS. The current evidence is weak but suggests that diverticulosis, colorectal cancer, structural small bowel disease (celiac disease, Crohn disease, and tumors), infl ammatory bowel disease, and ovarian cancer are the most common mimics of IBS. The effectiveness of using concerning symptoms to identify patients with underlying structural disease is disappointing ( 27 ) . Overall, in the absence of a better discriminator, concerning symptoms must still play a role in separating those patients with IBS symptoms, who require further evaluation to exclude structural disease, from those who do not. Further investigations, including diagnostic imaging, are not required in patients with IBS without alarm symptoms ( 27 ) .
In conclusion, despite the proliferation of guidelines that comment on the issue, this article demonstrates that there is a striking dearth of robust evidence and prospective studies, in particular, regarding the appropriate use of radiologic imaging in patients with IBS. 
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